Fludeoxyglucose F 18

CHEMBL2030434 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

181.2 g/mol

LogP

-2.4

Phase

4

This radioactive form of glucose is injected before a PET scan to detect areas of high metabolic activity in the body, including cancer cells and active areas of the brain. Tumors and inflamed tissues absorb more of this tracer, making them visible on imaging.

Peso Molecular

181,1500 g/mol

LogP

-2,40

TPSA

98,00 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Endometriosis Benign Prostatic Hyperplasia Cardiovascular Disease Respiratory Disease Pain Management Non-Small Cell Lung Cancer Rheumatoid Arthritis Asthma Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Epilepsy Schizophrenia Bipolar Disorder Melanoma Oncology Inflammatory Bowel Disease Multiple Sclerosis Non-Alcoholic Fatty Liver Disease Stroke Deep Vein Thrombosis / Pulmonary Embolism Hyperlipidemia Obesity Lymphoma Type 2 Diabetes Hypertension Major Depressive Disorder Breast Cancer Atopic Dermatitis Gout Chronic Pain HIV/AIDS Tuberculosis Heart Failure Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

OC[C@H]1OC(O)[C@H]([18F])[C@@H](O)[C@@H]1O

InChI

InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3-,4-,5-,6?/m1/s1/i7-1

Molecular Formula

C6H11FO5

HBD / HBA

4 / 6

Ligações Rotacionáveis

5

Átomos Pesados

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This radioactive form of glucose is injected before a PET scan to detect areas of high metabolic activity in the body, including cancer cells and active areas of the brain. Tumors and inflamed tissues absorb more of this tracer, making them visible on imaging.

Yes, Fludeoxyglucose F 18 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2030434. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 68614. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Fludeoxyglucose F 18 no PillFYI

Estrutura

Dados Rápidos

Fórmula: C6H11FO5

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.